BioHarvest Sciences Inc. Common Stock
BHSTNASDAQBasic Materials● Active
$3.18
$-0.01(-0.31%)
Market Cap$55102086
P/E Ratio—
52W High$12.8
52W Low$3.0602
BioHarvest Sciences Inc. Common Stock（BHST）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · BHST · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $34.51M | $25.19M | $12.67M | $5.50M | $2.10M |
| Cost of Revenue | $14.03M | $11.25M | $7.04M | $4.28M | $1.43M |
| Gross Profit | $20.48M | $13.94M | $5.63M | $1.22M | $0.67M |
| Gross Margin %(computed) | 59.34% | 55.35% | 44.45% | 22.17% | 31.87% |
| Operating Expenses | |||||
| R&D Expenses | $5.31M | $4.80M | $3.37M | $2.31M | $4.13M |
| G&A Expenses | $5.93M | $5.41M | $5.68M | $5.05M | $1.80M |
| Total Operating Expenses | $26.05M | $20.93M | $15.60M | $11.83M | $9.16M |
| Operating Income | ($5.58M) | ($6.99M) | ($9.97M) | ($10.61M) | ($8.49M) |
| Operating Margin %(computed) | -16.16% | -27.75% | -78.65% | -193.02% | -403.95% |
| Interest Income | $0.05M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $2.72M | $1.93M | $1.96M | $1.40M | $0.81M |
| Income Before Tax | ($11.06M) | ($12.90M) | ($12.56M) | ($11.24M) | ($9.83M) |
| Income Tax Expense | $0.08M | $0.01M | $0.00M | $0.00M | $0.00M |
| Net Income | ($11.13M) | ($12.91M) | ($12.56M) | ($11.24M) | ($9.83M) |
| Net Margin %(computed) | -32.27% | -51.27% | -99.15% | -204.37% | -467.51% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.60 | $-0.80 | $-0.93 | $-0.70 | $-0.70 |
| Wtd Avg Shares | 18.41M | 16.19M | 13.53M | 13.05M | 12.45M |
| EBITDA | ($6.71M) | ($9.72M) | ($9.76M) | ($9.13M) | ($8.64M) |
| EBITDA Margin %(computed) | -19.45% | -38.61% | -77.04% | -165.97% | -410.87% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解BioHarvest Sciences Inc. Common Stock
关于BioHarvest Sciences Inc. Common Stock（BHST）损益表
BioHarvest Sciences Inc. Common Stock（BHST）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，BHST实现营收$0.03B，毛利润$0.02B（毛利率59.34%），净利润($0.01B)（净利率-32.27%）。
常见问题
BHST · 4 问BioHarvest Sciences Inc. Common Stock（BHST）2025财年营收为$0.03B，同比up37.0%。
BHST revenueBHST salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08